• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ASTMH 2012

11-15 November 2012

Atlanta, USA

DNDi hosted a session entitled “Post-Kala-Azar Dermal Leishmaniasis (PKDL): A Neglected Entity in Visceral Leishmaniasis: Introduction of a PKDL Consortium”, and also presented oral presentations and several posters.

See a Summary of DNDi‘s activities !

[Tuesday, Nov 13, 2012, 10:15 AM -12:00 PM]

 Post-Kala-Azar Dermal Leishmaniasis (PKDL): A Neglected Entity in Visceral Leishmaniasis: Introduction of a PKDL Consortium  
DNDi session 

More info

DNDi hosted a session entitled “Post-Kala-Azar Dermal Leishmaniasis (PKDL): A Neglected Entity in Visceral Leishmaniasis: Introduction of a PKDL Consortium”, and also presented oral presentations and several posters.

P. falciparum parasite clearance in patients treated with artesunate-amodiaquine (ASAQ) vs. comparator groups, sub-Saharan Africa by Julien Zwang, Grant Dorsey, Abdoulaye Djimdé, Corine Karema, Andreas Mårtensson, Jean-Louis Ndiaye, JP Guthmann, Sodiomon Sirima, Phillipe Brasseur, Umberto d’Alessandro, Piero L. Olliaro

Clinical tolerability of artesunate-amodiaquine vs. comparator treatments for uncomplicated falciparum malaria in Sub-Saharian Africa, an individual patient data analysis by Zang, Dorsey, Djimdé, Karema, Martensson, Ndiaye, Sirima, Olliaro

Changes in malaria prevalence and health provider’s behaviour toward fever with the introduction of ACT and RDT at peripheral health centre level in South-western Senegal (2000-2011) by P. Brasseur, M. Badiane, M. Cisse, M. Vaillant, P. Olliaro

Other events

Loading...
11-13 October 2026

Berlin, Germany & Online

World Health Summit 2026

14-17 September

Copenhagen, Denmark

Hepatitis C virus, flaviviruses and related viruses (HCV-Flavi) 2026

25-28 August 2026

Addis Ababa, Ethiopia

Seventy-sixth session of the WHO Regional Committee for Africa

16-19 August 2026

Brasilia, Brazil

61st Congress of the Brazilian Society of Tropical Medicine (Medtrop 2026)

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Youtube Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license